Skip to main content

Table 2 Stimulation cycle characteristics of the Euploid embryos group versus the aneuploid embryos group

From: Predictive factors of aneuploidy in infertile patients undergoing IVF: a retrospective analysis in a private IVF practice

 

Euploid (N = 703)

Aneuploid (N = 539)

p-valuea

Estrogen (pg/ml)

42.94 ± 16.31

42.90 ± 15.90

0.839

FSH (mIU/ml)

6.33 ± 1.67

6.23 ± 1.78

0.499

LH (mIU/ml)

6.19 ± 2.75

5.83 ± 2.51

0.062

Progesterone (ng/ml)

0.25 ± 0.14

0.25 ± 0.15

0.251

No of oocytes

23.85 ± 10.73

24.40 ± 11.59

0.738

No of mature oocytes

19.45 ± 8.85

19.63 ± 9.38

0.963

No of fertilized oocytes

16.40 ± 7.41

16.69 ± 7.78

0.739

No of blasts

9.42 ± 5.10

9.43 ± 4.99

0.783

Gonadotropin used

  

0.252

 hpHMG1

316 (44.9%)

253 (47%)

 

 rFSH2 alone

230 (32.7%)

165 (30.6%)

 

 rFSH + rLH3

157 (22.4%)

121 (22.5%)

 

Trigger taken

  

0.221

 GnRH agonist

577 (82.1%)

421 (78.3%)

 

 Dual trigger

70 (10%)

72 (13.4%)

 

 Rec hCG4

56 (8%)

45 (8.4%)

 
  1. 1Highly purified human menopausal gonadotropin
  2. 2Recombinant FSH
  3. 3Recombinant LH
  4. 4Recombinant human chorionic gonadotropin
  5. ap-value less than 0.05 is considered significant